Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Effect of AF on Outcomes in Women Undergoing TAVI

Am J Cardiol; ePub 2018 Sep 7; Guedeney, et al

Among women undergoing contemporary transcatheter aortic valve implantation (TAVI), the presence of atrial fibrillation (AF) as baseline was associated with significantly increased 12-month mortality, a recent study found. Patients from the Women’s International Transcatheter Aortic Valve Implantation (Win-TAVI) registry with available electrocardiogram (ECG) at baseline were compared according to the presence of AF. Researchers found:

  • Of 993 women with available baseline ECG included in the study, 200 (20.1%) presented with AF.
  • Patients with AF at baseline had higher Euroscore I score values and more frequently had chronic kidney disease or prior stroke; those without AF more frequently had coronary artery disease (CAD).
  • In multivariate analysis, AF at baseline was associated with an increase of all-cause and cardiovascular death at 12 months.
  • Patients with AF had longer length of hospital stay.

Citation:

Guedeney P, Chieffo A, Snyder C, et al. Impact of baseline atrial fibrillation on outcomes among women undergoing contemporary transcatheter aortic valve implantation (from the Win-TAVI registry). [Published online ahead of print September 7, 2018]. Am J Cardiol. doi:10.1016/j.amjcard.2018.08.036.